Diseases /

Refractory Cytopenia with Multilineage Dysplasia

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. (WHO, 2001) [1]

Clinical Trials

View Clinical Trials for Refractory Cytopenia with Multilineage Dysplasia

Disease Details

Synonyms
Refractory Cytopenia w/ Multilineage, MDS with Multilineage Dysplasia, Myelodysplastic Syndrome with Multilineage Dysplasia, MDS-MLD, RCMD
Parent(s)
Myelodysplastic Syndromes
Children
Refractory Cytopenia with Multilineage Dysplasia and Ring Sideroblasts
OncoTree Name
MDS with Multilineage Dysplasia
OncoTree Code
MDSMD

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.